( en | de | ru )

 

Disambiguation of "Parmigiani, Giovanni"

Author of the publication

copydeleteadd this publication to your clipboard
Using Machine Learning and Natural Language Processing to Review and Classify the Medical Literature on Cancer Susceptibility Genes.

, , , , , , , , , , , and . CoRR, (2019)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Giovanni Natale

Giovanni Bacigalupo

Giovanni Caselotti

Giovanni Cennini

Giovanni Talarico

 

Other publications of authors with the same name

DeMix: deconvolution for mixed cancer transcriptomes using raw measured data., , , , , , and . Bioinform., 29 (15): 1865-1871 (2013)The consensus coding sequences of human breast and colorectal cancers., , , , , , , , , and 19 other author(s). Science, 314 (5797): 268-74 (2006)Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation, , and . Proceedings of the National Academy of Sciences, 110 (6): 1999-2004 (2013)Cross-study validation for the assessment of prediction algorithms., , , , , , and . Bioinform., 30 (12): 105-112 (2014)Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis., , , and . Bioinform., 30 (21): 3062-3069 (2014)Multi-Study Boosting: Theoretical Considerations for Merging vs. Ensembling., , , and . CoRR, (2022)Merging versus Ensembling in Multi-Study Machine Learning: Theoretical Insight from Random Effects., , and . CoRR, (2019)Cross-Cluster Weighted Forests., , and . CoRR, (2021)Prediction of Hereditary Cancers Using Neural Networks., , , and . CoRR, (2021)Adaptive platform trials: definition, design, conduct and reporting considerations, , , , , , , , , and 39 other author(s). Nature reviews. Drug discovery, 18 (10): 797-807 (October 2019)Disseny; Dissenys adaptatius; Platform trials; Exemples.